Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival: Results from the do tirofiban and reoprogive similar efficacy outcome trial (TARGET)

✍ Scribed by Albert W Chan; David J Moliterno; Peter B Berger; Gregg W Stone; Peter M DiBattiste; Steven L Yakubov; Shelly K Sapp; Kathy Wolski; Deepak L Bhatt; Eric J Topol

• Book ID: 119545871
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 137 KB
• Volume: 42
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(03)00944-6